A randomised trial of high-flow nasal cannula in infants with moderate bronchiolitis.

Philippe DurandTamma GuiddirChristèle KyhengFlorence BlancOlivier VignaudRalph EpaudFrédéric DugelayIsabelle BreantIsabelle BadierVanessa Degas-BussièreFlorence PhanValérie Soussan-BaniniAgnès LehnertCélestin MbambaCatherine BarreyCédric TahiriMarion DecobertMarie Saunier-PernaudetIrina CraiuMélanie TaveiraVincent Gajdosnull null

Published in: The European respiratory journal (2020)

In patients with moderate bronchiolitis, there was no evidence of lower rate of escalating respiratory support among those receiving HFNC therapy.

Keyphrases

respiratory syncytial virus
high intensity
extracorporeal membrane oxygenation
study protocol
open label
respiratory failure
chronic rhinosinusitis
randomized controlled trial
mesenchymal stem cells
smoking cessation